▲ Peaking
Business
🔮 holds
GLP-1s
16 independently sourced, verified news trends involving GLP-1s.
Coverage evidence
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 2 news categories, from Jun 29, 2026 through Oct 9, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
▲ Peaking
Health
🔮 holds
Scientists May Have Found How to Limit Weight Regain After Stopping GLP-1s
▲ Peaking
Health
🔮 holds
Some who take GLP-1s are suffering serious side effects, but it's unclear how often
◼ Archived
Health
🔮 fades ✓
Once described as obesity medicines for 'patients,' GLP-1s are increasingly lifestyle drugs for 'customers'
◼ Archived
Health
🔮 holds ✗
Is long-term use of GLP-1s safe?
◼ Archived
Health
🔮 holds ✗
Nearly 1 in 6 Kids on GLP-1s Developed This Problem Within a Year
◼ Archived
Health
🔮 fades ✓
The Best Strength Training Exercises for People Taking GLP-1s, According to an Expert
◼ Archived
Health
🔮 holds ✗
The dangerous risks of stopping Ozempic and GLP-1s
◼ Archived
Business
🔮 fades ✓
Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
◼ Archived
Health
🔮 fades ✓
Millions of parents are taking GLP-1s. How should they talk to their kids about it?
◼ Archived
Health
🔮 fades ✓
GLP-1 Drugs May Have a Hidden Effect on Your Eyes, Study Finds
New safety guidance and a lawsuit spotlight a possible eye‑risk link in popular GLP-1 weight‑loss drugs.
◼ Archived
Health
🔮 holds ✗
GLP-1 weight loss drugs: What experts say about keeping weight off after stopping
Use of GLP-1 weight loss medications has reached a new high in the United States, sparking debate over long-term efficacy and accessibility.
◼ Archived
Health
🔮 fades ✗
GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds
A new economic study suggests a correlation between the use of GLP-1 weight-loss drugs and a 17% reduction in employee sick leave.
◼ Archived
Health
🔮 holds ✗
Does stopping a GLP-1 really doom you to regain all the weight?
Recent studies examine the long-term impact of discontinuing GLP-1 weight-loss medications like Ozempic and Wegovy.
◼ Archived
Business
🔮 holds ✗
Why your health plan doesn’t cover GLP-1s, according to a top insurance exec
Rising demand for GLP-1 weight-loss medications is straining budgets and prompting insurers and employers to limit coverage.
◼ Archived
Health
🔮 holds ✗
As weight loss drugs like Ozempic spread, Louisiana doctors, researchers help answer big questions
Medical researchers and clinicians are investigating whether GLP-1 weight loss drugs like Ozempic offer benefits beyond weight reduction, including longevity.